CoChat

Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders

Wiech, Norbert, Fisher, Jed, Helquist, Paul, Wiest, Olaf · 2009 · Current Topics in Medicinal Chemistry

The DOI matches its Crossref record.

Abstract

The dynamics of gene expression are regulated by histone acetylases (HATs) and histone deacetylases (HDACs) that control the acetylation state of lysine side chains of the histone proteins of chromatin. The catalytic activity of these two enzymes remodels chromatin to control gene expression without altering gene sequence. Treatment of cancer has been the primary target for the clinical development of HDAC inhibitors, culminating in approval for the first HDAC inhibitor for the treatment of cutaneous T cell lymphoma. Beyond cancer, HDAC inhibition has potential for the treatment of many other diseases. The HDAC inhibitors phenylbutyric acid, valproic acid, and suberoylanilide hydroxamic acid (SAHA) have been shown to correct errant gene expression, ameliorate the progression of disease, and restore absent synthetic or metabolic activities for a diverse group of non-cancer disorders. These benefits have been found in patients with sickle cell anemia, HIV, and cystic fibrosis. In vitro and in vivo models of spinal muscular atrophy, muscular dystrophy, and neurodegenerative, and inflammatory disorders also show response to HDAC inhibitors. This review examines the application of HDAC inhibition as a treatment for a wide-range of non-cancer disorders, many of which are rare diseases that urgently need therapy. Inhibition of the HDACs has general potential as a pharmacological epigenetic approach for gene therapy.

Overview

Integrity signals

Registry

Crossref · 10.2174/156802609788085241

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 75

Metadata

Authors
Wiech, N., Fisher, J., Helquist, P., & Wiest, O.
Venue
Current Topics in Medicinal Chemistry
Published
2009-02-01
Volume
9
Issue
3
Pages
257-271
ISSN
1568-0266 (ISSN-L)
OpenAlex
W2130332831
Cited by
66
References
0
Citations by year
2024: 1 · 2023: 2 · 2021: 1 · 2020: 3 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 8 · 2013: 6 · 2012: 5
FWCI
4.83
Type
journal article
Language
en
Open access
closed
Locations
  • Current Topics in Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
histone deacetylase inhibitors, histone acetyltransferase, chromatin remodeling, gene expression regulation, epigenetic therapy, sickle cell disease, HIV, cystic fibrosis, spinal muscular atrophy, muscular dystrophy, neurodegenerative diseases, inflammatory diseases, rare diseases, valproic acid, vorinostat, 4-phenylbutyric acid, cutaneous T-cell lymphoma
MeSH terms
Drug Therapy, Enzyme Inhibitors, Humans, Epigenesis, Genetic, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders. https://app.cochat.ai/papers/10.2174/156802609788085241
The paper
Wiech, N., Fisher, J., Helquist, P., & Wiest, O. (2009). Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/156802609788085241

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.